Latest Colinz Laboratories stock price
Colinz Laboratories P/E Ratio
COLINZ • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
22.99
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
22.99
Current Price
₹45.30
EPS (TTM)
₹1.97
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
48.09
Sector Median
27.37
Sector Rank
#11 of 140
Sector Percentile
7.9%
Key P/E Ratio Insights for Colinz Laboratories
- Trading at discount to sector average PE of 48.09
View the COLINZ equity price for detailed stock performance.
Related Pages for Colinz Laboratories
Additional stock information and data for COLINZ
Sector P/E Ratio Comparison
Comparing Colinz Laboratories with other companies in Healthcare sector
Sector Average
48.09
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |